Breast cancer chemoprevention - a vision not yet realized
Author:
Publisher
Wiley
Subject
Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2354.2008.00951.x/fullpdf
Reference38 articles.
1. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women;Barrett-Connor;New England Journal of Medicine,2006
2. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial;Baum;Lancet,2002
3. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial;Cauley;Breast Cancer Research and Treatment,2001
4. American Society of Clinical Oncology Breast Cancer Technology Assessment Working Group. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition;Chlebowski;Journal of Clinical Oncology,2002
5. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98;Coates;Journal of Clinical Oncology,2007
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-ĸB Signaling Pathways;Anticancer Research;2017-09-06
2. Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake;ecancermedicalscience;2015-11-24
3. Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer;Ways of Regulating Drugs in the 19th and 20th Centuries;2013
4. Abordaje en el cribado de cáncer mamario en grupos poblacionales de riesgo elevado;Radiología;2012-11
5. Breast cancer screening in high risk populations;Radiología (English Edition);2012-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3